Last reviewed · How we verify
NCT06738381
Digital Secondary Prevention After Atherosclerotic Cardiovascular Disease
NA trial testing Digital intervention and motivational counselling in Atheroscleroses, Coronary in 300 participants. Currently enrolling.
20 December 2026
Quick facts
| Lead sponsor | Vestre Viken Hospital Trust |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 300 |
| Start date | 3 February 2025 |
| Primary completion | 20 December 2026 |
| Estimated completion | 20 December 2026 |
| Sites | 1 location across Norway |
Drugs / interventions tested
- Digital intervention and motivational counselling
Conditions studied
- Atheroscleroses, Coronary — all drugs for Atheroscleroses, Coronary →
- Atheroscleroses, Cerebral — all drugs for Atheroscleroses, Cerebral →
- Atherosclerotic Ischemic Disease — all drugs for Atherosclerotic Ischemic Disease →
Sponsor
Vestre Viken Hospital Trust
Who can join
18 and older, any sex, with Atheroscleroses, Coronary or Atheroscleroses, Cerebral. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Atherosclerotic cardiovascular disease (ASCVD) remains a leading cause of morbidity and mortality worldwide and in Norway. Approximately 50% of the patients admitted to hospitals with an acute ASCVD event has had a previous event. The high number of patients being readmitted to hospitals with new ASCVD events is to a large degree explained by poor control of established risk factors such as high LDL-cholesterol, high blood pressure (BP), diabetes, obesity, smoking, and lack of physical activity, as well as poor adherence to evidence-based medication. This pragmatic, open-label proof-of-concept study conducted at three secondary care hospitals will randomly assign patients hospitalized with an ASCVD event to either: (i) brief advice, tailored discharge information to general practitioners, and a nurse-led outpatient visit (control), or (ii) the same interventions as (i) plus a single in-hospital motivational counselling session and access to a digital platform for a 6 months period with patient information/videos and an individualized treatment plan and follow-up plan. The primary end point will be between-group differences in the proportion who report having attended follow-up visits in primary (primary care physicians and community-based healthy life centres) and specialist (cardiac rehabilitation programs, hospital outpatient visits) healthcare after 8 weeks and 6 months follow-up. Secondary end points will be change in the SMART2 risk score and cardiovascular risk factors between baseline and 6 and 12 months follow-up. Exploratory end points will be changes in adherence to cardiovascular drugs, self-care behaviour, health literacy, patient activation, and quality of life.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06738381
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Atheroscleroses, Coronary
Currently open trials in the same condition.
- NCT06590012 — Evaluating the Impact of 'Tertinat' on Patients with Atherosclerosis-Related Cardiovascular Diseases · Phase 2 · recruiting
- NCT06182683 — Concurrent OCT and FFR-guided PCI in CAD · NA · recruiting
- NCT05567536 — Long Term Follow-up of Comparison of Clopidogrel vs. Aspirin Monotherapy After Drug-eluting Stent Implantation · active not recruiting
Other Vestre Viken Hospital Trust trials
Trials by the same sponsor.
- NCT07200713 — Effect Study of SMART Treatment for Youth · NA · not yet recruiting
- NCT06906419 — Arthroscopic Trochleaplasty in Chronic Relapsing Patellar Dislocations: A Follow-up Study · enrolling by invitation
- NCT06920654 — Stabilization of the Shoulder Joint Using a Latarjet-like Procedure. · enrolling by invitation
- NCT06912061 — A Needle Technique for Achilles Tendon Lengthening in Pediatric Patients: A Prospective Study on Efficacy, Safety, and F · NA · recruiting
- NCT06906406 — Health-Related Quality of Life in Children and Adolescents With Clubfoot · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06738381 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Vestre Viken Hospital Trust
- Last refreshed: 21 February 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06738381.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing